Merck Closing 16 Sites, Including Two in United States
07/09/2010
"Today's announcement is another important step as we successfully integrate our global operations on schedule and move forward with Merck's strategic priorities," said Richard T. Clark, chairman and CEO of Merck. "These changes are crucial to drive future growth and realize the promise of being a global healthcare leader for the long term. While we believe these actions are necessary to support Merck's competitive advantage, they required difficult decisions that will impact some of our colleagues, their families and local communities. We will implement our restructuring plans with the utmost care and respect for the hard-working and talented employees of Merck."
Merck expects that the consolidation will save the company $2.7 billion to $3.1 billion in 2012, just shy of its $3.5 billion cost-savings goal.
The company is closing research sites in Montreal and Cambridge, Massachusetts, along with others around the world. It will also shutter manufacturing plants in Miami Lakes, Florida, plus seven other global sites.
Project Announcements
Oldcastle APG Plans Lancaster, South Carolina, Operations
05/10/2025
Vantive Plans Deerfield, Illinois, Headquarters Operations
05/10/2025
SkyWest Airlines Plans Shreveport, Louisiana, Maintenance Operations
05/10/2025
Hissho Sushi Plans Rock Hill, South Carolina, Headquarters-Distribution Operations
05/09/2025
Nelson Brothers Expands Walker County, Alabama, Operations
05/04/2025
Kimberly-Clark Expands Aiken County, South Carolina, Distribution Operations
05/04/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
The Location Economics of Advanced Nuclear
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Is It Time to Start Planning for Quantum Data Centers?
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024